Home About Us Development Information Pipeline

Pipeline

Place: Japan
Development No.
Generic name
Therapeutic Category Stage
FF-31501
Autologous Synovial Mesenchymal Stem Cells
meniscus injury requiring meniscectomy  Approval(May 2026)

(As of May 2026)